Accuray Grants CEO Stephen La Neve Equity Awards Tied to Stock Performance

Reuters11-01
Accuray Grants CEO Stephen La Neve Equity Awards Tied to Stock Performance

Accuray Incorporated has granted equity inducement awards to Stephen La Neve, its new Chief Executive Officer. The package includes 1,500,000 restricted stock units that will vest in equal portions over four years, contingent on continued service. In addition, La Neve has received 1,500,000 performance-based restricted stock units (PSUs), divided into three tranches. Each tranche is tied to specific stock price goals, with vesting eligibility based on the company's stock price performance over a period ending September 30, 2031. The PSU tranches require stock price increases of at least 25%, 60%, and 90% above the starting price, or share prices of $2.00, $2.50, and $3.00, respectively, to qualify for vesting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accuray Incorporated published the original content used to generate this news brief via PR Newswire (Ref. ID: SF12505) on October 31, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment